Stockreport

GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer [Yahoo! Finance]

Forte Biosciences, Inc.  (FBRX) 
PDF SAN MARINO, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- GenVivo, Inc., a clinical-stage biopharmaceutical company pioneering a patented, off-the-shelf vector platform to [Read more]